M&A Deal Summary

Boston Scientific Acquires Guidant

On April 21, 2006, Boston Scientific acquired life science company Guidant for 24.6B USD

Acquisition Highlights
  • This is Boston Scientific’s 2nd transaction in the Life Science sector.
  • This is Boston Scientific’s largest (disclosed) transaction.
  • This is Boston Scientific’s 9th transaction in the United States.
  • This is Boston Scientific’s 1st transaction in Indiana.

M&A Deal Summary

Date 2006-04-21
Target Guidant
Sector Life Science
Buyer(s) Boston Scientific
Deal Type Add-on Acquisition
Deal Value 24.6B USD

Target

Guidant

Indianapolis, Indiana, United States
website
Guidant Corporation pioneers lifesaving technology, giving an opportunity for better life today to millions of cardiac and vascular patients worldwide. The company, driven by a strong entrepreneurial culture of more than 10,000 employees, develops, manufactures and markets a broad array of products and services that enable less invasive care for some of life's most threatening medical conditions.

Search 192,723 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Boston Scientific

Marlborough, Massachusetts, United States

website


Category Company
Founded 1979
Sector Medical Products
Employees45,000
Revenue 12.7B USD (2022)
DESCRIPTION
Entrance to Boston Scientific's corporate headquarters in Marlborough, Massachusetts.
Entrance to Boston Scientific's corporate headquarters in Marlborough, Massachusetts.

Boston Scientific is a medical technology company. Boston Scientific's products and technologies are used to diagnose or treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women's health, and chronic pain conditions. Boston Scientific was founded in 1979 and is based in Marlborough, Massachusetts.


DEAL STATS #
Overall 10 of 62
Sector (Life Science) 2 of 5
Type (Add-on Acquisition) 10 of 48
State (Indiana) 1 of 1
Country (United States) 9 of 47
Year (2006) 1 of 1
Size (of disclosed) 1 of 32
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2005-04-18 TriVascular

Santa Rosa, California, United States

TriVascular, Inc. is a medical device company that design and manufacture endovascular aortic repair (EVAR). TriVascular’s initial product offerings are novel endovascular grafts focused on significantly advancing EVAR.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2007-01-05 EndoTex Interventional Systems

Cupertino, California, United States

EndoTex Interventional Systems, Inc. is a medical device company provides carotid artery stent.

Buy -